Clinical Trial: Augmenting Language Therapy for Aphasia: Levodopa

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Augmenting Language Therapy for Aphasia: A Randomized Double-Blind Placebo-Controlled Trial of Levodopa in Combination With Speech-Language Therapy

Brief Summary: The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a stroke.